Trailing-twelve-month (TTM) revenue is $8.16 Billion with a year-over-year growth of +11.67%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,007,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-23 |
| Q4 FY2025Period ended 2025-12-31 | $1,889,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $2,079,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $2,185,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $8,160,000,000 |
Current P/S: $82,237,092,000 market capitalization ÷ $8,160,000,000 TTM revenue = 10.08x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.19B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Moodys Analytics | $3.3B | $3.8B | $2.8B | $3.1B | $4.4B | $4.8B |
| Moodys Investors Service | $2.1B | $2.4B | $2.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $571M | $596M | $556M | $577M | $629M | $699M |
| EMEA | $1.5B | $1.9B | $1.7B | $1.8B |
$8.16B
$8.16 Billion
+11.67%
vs. $7.31B a year ago (TTM)
+7.07%
5 Year compound annual growth rate
1 Year
+11.67%
3 Year
+13.85%
5 Year
+7.07%
10 Year
+9.00%
15 Year
+8.94%
20 Year
+7.71%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.72B | +$630.00M | +8.89% |
| 2024 | $7.09B | +$1.17B | +19.81% |
| 2023 | $5.92B | +$448.00M | +8.19% |
| 2022 | $5.47B | ($750.00M) | (12.06%) |
| 2021 | $6.22B | +$847.00M | +15.77% |
| 2020 |
TTM Growth
+11.67%
3-Year CAGR
+13.85%
5-Year CAGR
+7.07%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.7B |
| $2.9B |
| $2.4B |
| International Regions | $2.4B | $2.8B | $2.6B | $2.8B | $3.3B | $3.5B |
|---|
| U S | $300M | $340M | $357M | $393M | $449M | $472M |
|---|
| $5.37B |
| +$542.00M |
| +11.22% |
| 2019 | $4.83B | +$386.30M | +8.70% |
| 2018 | $4.44B | +$238.60M | +5.68% |
| 2017 | $4.20B | +$599.90M | +16.64% |
| 2016 | $3.60B | +$119.70M | +3.44% |
